Phase 1b/2a biotech developing tissue-specific therapies for solid tumors.
Industry: Health Care
Latest Trade: $1.79 0.00 (0.0%)
First Day Return: -26.6%
Return from IPO: -64.2%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/17/2021 |
Offer Price | $5.00 |
Price Range $5.00 - $6.00 | |
Offer Shares (mm) | 4.2 |
Deal Size ($mm) | $21 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 12/15/2021 |
Offer Price | $5.00 |
Price Range $5.00 - $6.00 | |
Offer Shares (mm) | 4.2 |
Deal Size ($mm) | $21 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
ThinkEquity |
Company Data | |
---|---|
Headquarters | Los Angeles, CA, United States |
Founded | 2012 |
Employees at IPO | 9 |
Website www.immixbio.com |